Bright Minds Biosciences
from OTCQB Podcast Hosted by OTC Markets Group
Bright Minds Biosciences (OTCQB: BMBIF), is a biotechnology company focused on developing novel treatments for neuropsychiatry disorders, epilepsy and pain. Dr. Gideon Shapiro, Vice President of Discovery joins us to discuss the safety and efficacy of psychedelic treatments and how Bright Minds' treatments differ from conventional medicine. View Podcast Transcript for Bright Minds Biosciences
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of OTCQB Podcast?
This episode is 17 minutes long.
When was this OTCQB Podcast episode published?
This episode was published on August 23, 2021.
Can I download this OTCQB Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.